Ursodiol in Huntington's disease
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 04 Feb 2009
At a glance
- Drugs Ursodeoxycholic acid (Primary)
- Indications Huntington's disease
- Focus Adverse reactions; Pharmacokinetics
- Acronyms UDCA-HD
- 31 Aug 2018 Biomarkers information updated
- 04 Feb 2009 Planned end date changed from Oct 2008 to Jun 2009 as reported by ClinicalTrials.gov.
- 04 Feb 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.